WO2002009649A3 - Conjugues peptides-medicaments integres dans des cellules - Google Patents
Conjugues peptides-medicaments integres dans des cellules Download PDFInfo
- Publication number
- WO2002009649A3 WO2002009649A3 PCT/US2001/024088 US0124088W WO0209649A3 WO 2002009649 A3 WO2002009649 A3 WO 2002009649A3 US 0124088 W US0124088 W US 0124088W WO 0209649 A3 WO0209649 A3 WO 0209649A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug conjugates
- lfa
- icam
- leukocytes
- side effects
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002417885A CA2417885A1 (fr) | 2000-08-01 | 2001-08-01 | Conjugues peptides-medicaments integres dans des cellules |
EP01956077A EP1311280A4 (fr) | 2000-08-01 | 2001-08-01 | Conjugues peptides-medicaments integres dans des cellules |
JP2002515204A JP2004505029A (ja) | 2000-08-01 | 2001-08-01 | 細胞内に取り込まれるペプチド−薬剤複合体 |
AU2001278113A AU2001278113A1 (en) | 2000-08-01 | 2001-08-01 | Cell internalized peptide-drug conjugates |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62971900A | 2000-08-01 | 2000-08-01 | |
US09/629,719 | 2000-08-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002009649A2 WO2002009649A2 (fr) | 2002-02-07 |
WO2002009649A3 true WO2002009649A3 (fr) | 2002-04-11 |
WO2002009649A8 WO2002009649A8 (fr) | 2002-08-01 |
Family
ID=24524196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/024088 WO2002009649A2 (fr) | 2000-08-01 | 2001-08-01 | Conjugues peptides-medicaments integres dans des cellules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1311280A4 (fr) |
JP (1) | JP2004505029A (fr) |
AU (1) | AU2001278113A1 (fr) |
CA (1) | CA2417885A1 (fr) |
WO (1) | WO2002009649A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006102395A2 (fr) * | 2005-03-22 | 2006-09-28 | Medstar Health Inc | Systemes et methodes d'administration pour le diagnostic et le traitement de maladies cardio-vasculaires |
KR101615161B1 (ko) * | 2011-02-02 | 2016-04-25 | 메디포스트(주) | 신경질환의 예방 또는 치료를 위한 icam-1의 용도 |
US11266717B2 (en) | 2016-08-12 | 2022-03-08 | Immunowork, Llc | Diagnosis, prevention, and/or treatment of autoimmune diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183805A (en) * | 1990-08-13 | 1993-02-02 | Board Of Regents, The University Of Texas System | Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2188287A1 (fr) * | 1994-04-19 | 1995-10-26 | Stephen Benedict | Peptides a chaine courte a base d'icam-1/lfa-1 et leur methode d'utilisation |
WO1997041149A1 (fr) * | 1996-04-26 | 1997-11-06 | The University Of Kansas | Compositions de petpides entraînant une tolerance immunitaire et leurs procedes d'utilisation |
-
2001
- 2001-08-01 EP EP01956077A patent/EP1311280A4/fr not_active Withdrawn
- 2001-08-01 CA CA002417885A patent/CA2417885A1/fr not_active Abandoned
- 2001-08-01 WO PCT/US2001/024088 patent/WO2002009649A2/fr not_active Application Discontinuation
- 2001-08-01 AU AU2001278113A patent/AU2001278113A1/en not_active Abandoned
- 2001-08-01 JP JP2002515204A patent/JP2004505029A/ja not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183805A (en) * | 1990-08-13 | 1993-02-02 | Board Of Regents, The University Of Texas System | Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
Non-Patent Citations (3)
Title |
---|
GURSOY ET AL.: "Binding and internalization of an ECAM-1 peptide by the surface receptor of T cells", J. PEPTIDES RES, vol. 53, April 1999 (1999-04-01), pages 414 - 421, XP002905947 * |
JOIS ET AL.: "Inhibition of homotypic adhesion of T cells: secondary structure of an ICAM-1-derived cyclic peptide", J. PEPTIDE RES., vol. 49, June 1997 (1997-06-01), pages 517 - 526, XP000657593 * |
See also references of EP1311280A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1311280A2 (fr) | 2003-05-21 |
AU2001278113A1 (en) | 2002-02-13 |
JP2004505029A (ja) | 2004-02-19 |
WO2002009649A8 (fr) | 2002-08-01 |
CA2417885A1 (fr) | 2002-02-07 |
WO2002009649A2 (fr) | 2002-02-07 |
EP1311280A4 (fr) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300903I2 (nl) | Inotuzumab ozogamicin | |
EP1374908A3 (fr) | Conjugués de polymère - médicament comprenant des groupes de liaison hydrazide | |
DE69934337D1 (de) | Konjugate zur Behandlung von Entzündungskrankheiten und von assozierter Gewebeschädigung | |
CY1117729T1 (el) | Μεθοδοι για την παρασκευη κυτταροτοξικων συζευγματων μεϋτανσινοειδων και παραγοντων δεσμευσης κυτταρου | |
WO2006089156A3 (fr) | Conjugue medicament-polymere couple a un peptide vecteur | |
WO2005081711A3 (fr) | Composes de monomethylvaline capables de conjugaison aux ligands | |
WO2004069159A3 (fr) | Conjugues de delivrance de medicaments de liaison au recepteur de vitamines | |
CA2118032A1 (fr) | Conjugues de toxines et de medicaments a usage therapeutique | |
EP1724353A3 (fr) | Méthode pour la formation de microparticules lipidiques couplées à des protéines | |
WO2002043771A3 (fr) | Conjugues de peptide glycosyle/galactosyle, lieur bifonctionnel et monomeres/polymeres nucleotidiques, et compositions et procedes d'utilisation associes | |
WO2007100385A3 (fr) | Conjugués anticorps-médicaments à base de depsipeptide macrocyclique et méthodes associées | |
WO2005053749A3 (fr) | Liaison liberable et compositions la contenant | |
DE69531342D1 (de) | Avidin-biotin immunokonjugate | |
WO2005014024A3 (fr) | Conjugues de polymere et de proteine lies au moyen d'un groupe de liaison oxime | |
WO2002091989A3 (fr) | Therapies antivirales a base de conjugues d'acides amines a une polyamine ou a des analogues de polyamine | |
EP1027061A4 (fr) | Polysaccharides formateurs d'imine, leur preparation, et leur utilisation en tant qu'adjuvants et immunostimulants | |
WO2008077956A3 (fr) | Conjugués oligonucléotide-, protéine- et/ou peptide-polymère | |
WO2009059309A3 (fr) | Lieurs de peptide clivables par furine pour des conjugués médicament-ligand | |
WO2003045319A3 (fr) | Agents therapeutiques cibles et leurs utilisations | |
WO2004050711A3 (fr) | Antigenes specifiques gp120, leurs conjugues, leur procedes de preparation et leur utilisation | |
WO2003035011A8 (fr) | Conjugues multimedicaments multiligands permettant une administration ciblee de medicaments | |
WO2003094842A3 (fr) | Conjugues comprenant un medicament agissant sur le systeme nerveux central, lequel medicament est lie a un acide glucuronique ou a une glucosamine par l'intermediaire d'une liaison amide, et utilisations correspondantes | |
WO2002009649A3 (fr) | Conjugues peptides-medicaments integres dans des cellules | |
AU1165899A (en) | Conjugates comprising two active agents | |
EP1351709B8 (fr) | Pegylation de lieurs ameliorant l'activite antitumorale et reduisant la toxicite d'immunoconjugues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WR | Later publication of a revised version of an international search report | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2417885 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002515204 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001278113 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001956077 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001956077 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001956077 Country of ref document: EP |